Comparison of enzyme-linked immunospot assay and tuberculin skin test in healthy children exposed to Mycobacterium tuberculosis

Pediatrics

Volumn 117, Issue 5, 2006, Pages 1542-1548

  Hill, Philip C ^a,c   Brookes, Roger H ^a   Adetifa, Ifedayo M O ^a   Fox, Annette ^a   Jackson Sillah, Dolly ^a   Lugos, Moses D ^a   Donkor, Simon A ^a   Marshall, Roger J ^b   Howie, Stephen R C ^a   Corrah, Tumani ^a   Jeffries, David J ^a   Adegbola, Richard A ^a   McAdam, Keith P W J ^a  

^a MULAGO HOSPITAL   (Uganda)

^b UNIVERSITY OF AUCKLAND   (New Zealand)

^c MEDICAL RESEARCH COUNCIL LABORATORIES   (Gambia)

Author keywords

ELISPOT; Mycobacterium tuberculosis; Tuberculin skin test; Tuberculosis

Indexed keywords

BCG VACCINE; BACTERIAL ANTIGEN;

ADOLESCENT; ARTICLE; BCG VACCINATION; CHILD; CONTROLLED STUDY; ENZYME LINKED IMMUNOSPOT ASSAY; FALSE POSITIVE RESULT; FEMALE; GAMBIA; HUMAN; INTERMETHOD COMPARISON; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MYCOBACTERIOSIS; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; SPUTUM SMEAR; TUBERCULIN TEST; COMPARATIVE STUDY; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; FAMILY HEALTH; IMMUNOLOGY; PRESCHOOL CHILD;

ADOLESCENT; ANTIGENS, BACTERIAL; BCG VACCINE; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FAMILY HEALTH; GAMBIA; HUMANS; MYCOBACTERIUM TUBERCULOSIS; TUBERCULIN TEST; TUBERCULOSIS, PULMONARY;

EID: 33646838922     PISSN: 00314005     EISSN: 02105721     Source Type: Journal    
DOI: 10.1542/peds.2005-2095     Document Type: Article

References (30)

1. Walls T, Shingadia D. Global epidemiology of paediatric tuberculosis. J Infect 2004;48:13-22
2. Dolin P, Raviglione M, Kochi A. Global tuberculosis incidence and mortality during 1990-2000. Bull World Health Organ 1994;72:213-220
3. Starke JR. Tuberculosis in children. In: Reichman LB, Hershfield ES, eds. Tuberculosis: A Comprehensive International Approach. New York, NY: Marcel Dekker Inc; 1993:329-367
4. Starke JR. Paediatric tuberculosis: time for a new approach. Tuberculosis. 2003;83:208-212
5. World Health Organization. Treatment of Tuberculosis: Guidelines for National Programmes. Geneva, Switzerland: World Health Organization; 2003
6. Huebner RE, Schein MF, Bass JB Jr. The tuberculin skin test. Clin Infect Dis 1993;17:968-975
7. Black GF, Weir RE, Floyd S, et al. BCG-induced increase in interferon gamma response to mycobacterial antigens and efficacy of BCG vaccination in Malawi and the UK: two randomised controlled studies. Lancet. 2002;359:304-307
8. Jasmer RM, Nahid P, Hopewell PC. Clinical practice: latent tuberculosis infection. N Engl J Med 2002;359:1393-1401
9. Demisse A, Ravn P, Olobo J, et al. T-cell recognition of Mycobacterium tuberculosis culture filtrate fractions in tuberculosis patients, and their household contacts. Infect Immunol 1999;67:5967-5971
10. Vekemans J, Lienhardt C, Sillah JS, et al. Tuberculosis contacts but not patients have higher gamma interferon responses to ESAT-6 than do community controls in the Gambia. Infect Immunol 2001;69:6554-6557
11. Lalvani A, Nagvenkar P, Udwadia Z, et al. Enumeration of T cells specific for RD 1 encoded antigens suggests a high prevalence of latent Mycobacterium tuberculosis infection in healthy urban Indians. J Infect Dis 2001;183:469-477
12. Ewer K, Deeks J, Alvarez L, et al. Comparison of T-cell based assay with tuberculin skin test for diagnosis of Mycobacterium tuberculosis infection in a school tuberculosis outbreak. Lancet. 2003;361:1168-1173
13. Hill PC, Brookes RH, Fox A, et al. Large-scale evaluation of enzyme-linked immunospot assay and skin test for the diagnosis of Mycobacterium tuberculosis infection against a gradient of exposure in the Gambia. Clin Infect Dis 2004;38:966-973
14. Heifets LB, Good RB. Current laboratory methods for the diagnosis of tuberculosis. In: Bloom BR, ed. Tuberculosis: Protection, Pathogenesis, and Control. Washington, DC: American Society for Microbiology; 1994:85-110
15. Lalvani A, Brookes R, Hambleton S, Britton WJ, Hill AV, McMichael AJ. Rapid effector function in CD+ memory T cells. J Exp Med 1997;186:859-865
16. Jeffries DJ, Hill PC, Fox A, et al. Determination of ELISPOT assay and PPD skin test cut-offs for the diagnosis of Mycobacterium tuberculosis in the Gambia. Int J Tuberc Lung Dis 2006;10:192-198
17. Lienhardt C, Fielding K, Sillah J, et al. Risk factors for tuberculosis infection in sub-saharan Africa: a contact study in The Gambia. Am J Respir Crit Care Med 2003;168:448-455
18. Lienhardt C, Sillah J, Kielding K, et al. Risk factors for tuberculosis in children in contact with infectious tuberculosis cases in the Gambia, West Africa. Pediatrics. 2003;111(5). Available at: www.pediatrics.org/cgi/ content/full/111/5/e608
19. Marshall RJ. Displaying clinical data relationships using scaled rectangle diagrams. Stat Med 2001;20:1077-1088
20. Ulrichs T, Munk ME, Mollenkopf H, et al. Differential T cell responses to Mycobaterium tuberculosis ESAT6 in tuberculosis patients and healthy donors. Eur J Immunol 1998;28:3949-3958
21. Pathan AA, Wilkinson KA, Klenerman P, et al. Direct ex vivo analysis of antigen specific IFN-γ-secreting CD4 T cells in Mycobacterium tuberculosis-infected individuals: associations with clinical disease state and effect of treatment. J Immunol 2001;167:5217-5225
22. Haile Y, Bjune G, Wiker HG. Expression of the mceA, esat-6 and hspX genes in Mycobacterium tuberculosis and their responses to aerobic conditions and to restricted oxygen supply. Microbiology. 2002;148:3881-3886
23. Fortune SM, Jaeger A, Sarracino DA, et al. Mutually dependent secretion of proteins required for mycobacterial virulence. PNAS. 2005;102:10676-10681
24. Fine PEM, Bruce J, Ponninghaus JM, Nkhosa P, Harawa A, Vynnycky E. Tuberculin sensitivity: conversions and reversions in a rural African population. Int J Tuberc Lung Dis 1999;3:962-975
25. Mudido PM, Guwatudde D, Nakakeeto MK, et al. The effect of Bacille Calmette-Guerin vaccination at birth on tuberculin skin reactivity in Ugandan children. Int J Tuberc Lung Dis 1999;3:891-895
26. Almeida LM, Barbieri MA, Da Paixao AC, et al. Use of the purified protein derivative to assess the risk of children in close contact with adults with tuberculosis in a population with high Calmette-Guerin bacillus coverage. Pediatr Infect Dis J 2001;20:1061-1065
27. Pai M, Kaustubh G, Rajnish J, et al. Mycobacterium tuberculosis infection in health care workers in rural India. Comparison of a whole blood interferon gamma assay with tuberculin skin testing. JAMA. 2005;293:2746-2755
28. Wang L, Turner MO, Elwod RK, Schulzer M, FitzGerald JM. A meta-analysis of the effect of Bacille Calmette Guerin vaccination in tuberculin skin test measurements. Thorax. 2002;57:804-809
29. Guwatudde D, Nakakeeto M, Jones-Lopez EC, et al. Tuberculosis in household contacts of infectious cases in Kampala, Uganda. Am J Epidemiol 2003;158:887-898
30. Young TK, Mirdad S. Determinants of tuberculin sensitivity in a child population covered by mass BCG vaccination. Tuber Lung Dis 1992;73:94-100